6630--Cost Per Reportable Result (CPRR) HbA1c Testing - Base 4 Chillicothe VAMC
Veterans Affairs · 250-NETWORK CONTRACT OFFICE 10 (36C250)
No listed company matched (Materiality N/A)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 36C25026Q0133 in this department, oldest first.
- Feb 20, 2026 · this noticeAward NoticeTOSOH BIOSCIENCE, INC. · $27K
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Note the winner and the end of the period of performance for the recompete.
- Follow the agency to see the next notice for this work.
What the notice says
Department of Veterans Affairs, Network Contracting Office 10 located at 260 E University Avenue, Cincinnati, OH 45219-2356, in support of Veterans Integrated Service Network (VISN) 10, Chillicothe VA Medical Center (VAMC) Pathology & Laboratory Medicine Service (P&LMS), located at 17273 State Route 104, Chillicothe, OH 45601-9718 awarded a firm fixed price Federal Supply Schedule (FSS) Blanket Purchase Agreement (BPA) for annual Hemoglobin A1c Cost Per Reportable Result (CPRR) testing to Tosoh Bioscience, Inc. under FSS Contract V797D-40130. Tosoh Bioscience, Inc Large Business 360 Gantz Road… (show all)
Grove City, Ohio 43123-1895 The acquisition includes the supply of test kits, contractor owned equipment, supplies, and customer support to perform in-house testing services for veteran patients. The period of performance (POP) will be a base year with four 1-Year ordering options. The annual cost is $27,000.00. The total cost including all option years is $135,000.00.
Who won similar work
12 award notices on SAM.gov in the last 24 months. Matched by: Same office (250-NETWORK CONTRACT OFFICE 10 (36C250)), same NAICS 334516.
Single-winner award sizes (12): middle half $38K to $513K, median $176K; range $24K to $1.8M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| ROCHE DIAGNOSTICS CORPORATION | 3 | $2.7M | Apr 30, 2026 |
| LEICA MICROSYSTEMS INC. | 2 | $734K | Feb 12, 2026 |
| BECKMAN COULTER, INC | 1 | $532K | Sep 30, 2025 |
| QUIDELORTHO SALES COMPANY · $QDEL · $3.0B | 1 | $125K | Oct 1, 2026 |
| AGILENT TECHNOLOGIES INC · $A · $6.8B | 1 | $69K | Jan 30, 2025 |
| LI-COR BIOTECH, LLC | 1 | $39K | Jul 28, 2026 |
| HARVARD BIOSCIENCE INC · $HBIO · $94.1M | 1 | $36K | Jul 29, 2026 |
| KEYENCE CORPORATION | 1 | $35K | May 14, 2026 |
| ABBOTT LABORATORIES INC. | 1 | $24K | Jul 23, 2026 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- $QDEL reported $3.0B revenue in FY2025. The median single-winner award in these 12 past awards, $176K, is under 0.1% of that. 10-K
- $A reported $6.8B revenue in FY2025. The median single-winner award in these 12 past awards, $176K, is under 0.1% of that. 10-K
- $HBIO reported $94.1M revenue in FY2025. The median single-winner award in these 12 past awards, $176K, is 0.2% of that. 10-K
One award's total value against one year of revenue; many awards are paid over several years.
- Oct 1, 2026QUIDELORTHO SALES COMPANY$125K6550--Blood Bank Reagents 5 Year OP IDIQ - DetroitMateriality: <0.01% of $QDEL revenue (Low) SEC
- Jul 29, 2026HARVARD BIOSCIENCE INC$36K6640--Supplies - Animal Telemetry Devices - Ann ArborMateriality: 0.04% of $HBIO revenue (Low) SEC
- Jul 28, 2026LI-COR BIOTECH, LLC$39K6640--EQUIPMENT, Odyssey XF Imaging Bundle, DetroitNo listed company matched (Materiality N/A)
- Jul 23, 2026ABBOTT LABORATORIES INC.$24K6640--Equipment - Piccolo Analyzer w/5-yr Service & Panels - 610Materiality: <0.01% of $ABT revenue (Low) SEC
- May 14, 2026KEYENCE CORPORATION$35K6640--Equipment - BZ-X Microscope Accessories - Research Service - Ann ArborNo listed company matched (Materiality N/A)
- Apr 30, 2026ROCHE DIAGNOSTICS CORPORATION$564K6640--Award Notice - Roche 6-month Bridge - NIHCS POP: 5/1/26-10/31/2026; PO 610C60131No listed company matched (Materiality N/A)
- Feb 12, 2026LEICA MICROSYSTEMS INC.$227KLEICA CEREBRO TRACKING SYSTEMNo listed company matched (Materiality N/A)
- Jan 5, 2026ROCHE DIAGNOSTICS CORPORATION$1.8MCPT - Roche Cobas 6800 Testing (with service/maintenance)-No listed company matched (Materiality N/A)
- Oct 1, 2025LEICA MICROSYSTEMS INC.$507KLeica Preventative Maintenance LTC Charles S. Kettles VA Medical CenterNo listed company matched (Materiality N/A)
- Sep 30, 2025BECKMAN COULTER, INC$532KURINALYSIS CLEVELANDNo listed company matched (Materiality N/A)
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (0 filings)
- 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 25 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 3 of the past winners are listed companies
- 0 insider buys and 1 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.